Formulation Development Services: Market Size & Forecast 2026

The global formulation development outsourcing market sits at approximately USD 37.3 billion in 2025 (base year), growing at roughly 8.2% CAGR through 2032 to reach an estimated USD 64.5 billion. The market is held in a structurally tight balance between accelerating biopharmaceutical R&D outsourcing, chronic CDMO capacity constraints in injectables and oral solid dose, and rising formulation complexity driven by poorly soluble molecules and new delivery modalities. Pharma-grade excipient feedstocks, lactose, microcrystalline cellulose, and specialty polymers, trade in a USD 3,600, 4,200/MT band across Asia, Europe, and the US, and pass through CDMO contracts with a 15, 25% markup. Buyer Power Score of -2.0, supplier-favoring: concentrated CDMO capacity, high switching costs from regulatory qualification and technology transfer obligations, and double-digit demand growth from biotech spo

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.